Home/Filings/4/0001209191-17-040835
4//SEC Filing

Juno Therapeutics, Inc. 4

Accession 0001209191-17-040835

CIK 0001594864operating

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:32 PM ET

Size

5.4 KB

Accession

0001209191-17-040835

Insider Transaction Report

Form 4
Period: 2017-06-16
Barron Hal
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-06-16+12,00012,000 total
    Exercise: $23.29Exp: 2027-06-15Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]100% of the shares subject to the option become vested and exercisable on the earlier of (i) the date of the 2018 Annual Meeting of Stockholders and (ii) the first anniversary of the grant date, in either event, subject to the director continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through such date.

Issuer

Juno Therapeutics, Inc.

CIK 0001594864

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001594864

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:32 PM ET
Size
5.4 KB